evidence: Misleading: The lawsuit has no bearing on whether ivermectin is effective against COVID-19. Well-performed clinical trials didn’t find that ivermectin produces meaningful benefits in COVID-19 patients. Ivermectin remains unapproved and unauthorized by the FDA for treating COVID-19. [...] Notably, the complaint clarified that "[t]his case is not about whether ivermectin is an effective treatment for COVID-19. It’s about who determines the appropriate treatment for each unique patient and whether the FDA can interfere with that process". This piece of information becomes relevant later on, as we will see. [...] Claims that a court found the FDA broke the law with its ivermectin advisory or that it lost the case are inaccurate and misrepresent the outcome of the case. Furthermore, the outcome also has no bearing on whether ivermectin is effective for COVID-19. Multiple clinical trials have detected no meaningful benefit from treating COVID-19 with ivermectin.